CPNG The Buyback Finally Executed - Right as the Record Margins Cooled Off

A Buyback That Finally Executed, a Margin That Finally Cooled

Coupang's third quarter of 2025 answers one question this site has been asking since May and raises another. Total net revenues grew 17.8% YoY to $9.267 billion, and free cash flow swung to $442 million from a $(42) million loss a year earlier - the reversal this site flagged as the thing to watch last quarter, and it arrived because capital expenditure actually fell YoY to $353 million (from $380 million), not because operating cash flow merely held up: net cash from operations more than doubled to $792 million. And the $1 billion buyback authorized in May 2025, which sat completely unused through Q2, finally moved - Coupang repurchased 2.8 million Class A shares for $81 million this quarter, an average price of roughly $29 a share.

But the record-setting Product Commerce margin that defined last quarter didn't hold. Segment Adjusted EBITDA margin for Product Commerce came in at 8.83% this quarter - still comfortably ahead of Q3 2024's 6.8%, but a step back from Q2 2025's all-time high of 9.04%. Consolidated Adjusted EBITDA margin followed the same pattern: 4.5% this quarter versus Q2's record 5.0%. Read together, this is a genuinely good quarter on cash generation and capital return that arrived alongside a genuinely worse quarter on margin than the one immediately before it - both things are true, and a reader tracking only one would get a different picture of the business than a reader tracking both. See Beyond the Usual below for what's actually driving the margin softness.

The Prescription

Coupang should keep quantifying its capital commitments the way it did this quarter - naming the $365 million of remaining fulfillment-center construction spend, the specific interest rate (3.80%) and structure of the new unsecured term loan, the exact reason management gave for Developing Offerings' wider loss (increased investment in Taiwan). That kind of specific disclosure is what let this post identify Taiwan, not Farfetch, as this quarter's actual drag - without it, "Developing Offerings" reads as one undifferentiated bucket getting worse for no stated reason.

What it should stop doing: reporting Developing Offerings as a single segment covering four businesses at four different maturity stages - Farfetch (post-acquisition, loss-narrowing), Eats and Play (mature, likely near-breakeven), Taiwan (new investment, presumably loss-widening), and fintech - without breaking out even directional detail on each. This quarter's 130% YoY jump in the segment's dollar loss could be read as Farfetch backsliding, Eats deteriorating, or new Taiwan spend - and only the MD&A's one-line explanation (Taiwan) tells a reader it's the last of those. A segment that can hide a genuine backslide in one sub-business behind investment in another isn't disclosing enough to be evaluated properly quarter to quarter.

Key Financial Metrics

Q3 2025 vs. Q3 2024 - reported in USD, figures from this 10-Q's condensed consolidated financial statements

Coupang reports natively in US dollars, so no FX conversion is needed here. Figures are drawn directly from this Form 10-Q's condensed consolidated financial statements and MD&A tables, covering the quarter ended September 30, 2025.

Metric	Q3 2025	Q3 2024	YoY
Total net revenues	$9,267M	$7,866M	✅ +17.8%
Gross profit	$2,720M	$2,269M	✅ +19.9%, margin 29.4% vs 28.8%
Operating income	$162M	$109M	✅ +48.6%
Adjusted EBITDA»	$413M	$343M	✅ +20.4%, margin 4.5% vs 4.4%
Income before income taxes	$165M	$132M	✅ +25.0%
Income tax expense	$70M	$68M	⚠️ +2.9%, effective rate 42.4% vs 51.5%
Net income (consolidated)	$95M	$64M	✅ +48.4%
Net income attributable to Coupang stockholders	$95M	$70M	✅ +35.7%
Net cash provided by operating activities	$792M	$334M	✅ +137.1%
Free cash flow»	$442M	$(42)M	✅ swung positive
Cash & cash equivalents (period end)	$7,229M	-	vs $5,879M at Dec 2024

Balance sheet metric	Sep 2025	Dec 2024	Change
Total assets	$18,668M	$15,344M	✅ +21.7%
Total liabilities	$13,927M	$11,167M	⚠️ +24.7%
Total equity	$4,741M	$4,102M	✅ +15.6%
Redeemable noncontrolling interest	$0M	$75M	- unchanged since Greenoaks' exit, see prior quarter

Total short- and long-term debt (short-term borrowings, current portion of long-term debt, and long-term debt) rose to $1.989 billion at quarter-end from $1.533 billion at year-end, reflecting both the July 2025 revolving-credit draw and a new term loan entered this quarter - see Beyond the Usual. Capital expenditure (purchases of property and equipment) actually fell to $353 million from $380 million a year ago - a reversal of the near-doubling this site flagged in Q1 and Q2 of this year, and the first YoY capex decline in several quarters. Long-term operating lease obligations rose 37.9% YoY to $2.441 billion from $1.770 billion, continuing the fulfillment-center expansion pattern, though the sequential increase from Q2's $2.270 billion (7.5%) was smaller than the prior two quarters' jumps.

The effective tax rate improved to 42.4% from 51.5% a year ago - still far above the U.S. statutory rate, but a real narrowing rather than the "non-meaningful" comparisons this site tracked through mid-2025. The filing attributes part of the decrease to provisions of the "One Big Beautiful Bill Act" (OBBBA), enacted July 4, 2025, which reduced U.S. taxes on foreign earnings; Coupang describes the impact on this quarter's tax provision as immaterial in isolation but it's a genuine, disclosed structural tailwind rather than a one-off item.

Segment Performance: Product Commerce vs. Developing Offerings

Coupang reports the same two segments as every quarter since Q1 2022: Product Commerce (core retail, marketplace, Rocket Fresh, and related advertising) and Developing Offerings (Coupang Eats, Coupang Play, Taiwan retail, fintech, and Farfetch).

Metric	Product Commerce Q3 2025	Product Commerce Q3 2024	Developing Offerings Q3 2025	Developing Offerings Q3 2024
Net revenues	$7,980M	$6,891M	$1,287M	$975M
Revenue growth	✅ +15.8%	-	✅ +32.0%	-
Segment Adjusted EBITDA	⚠️ $705M (margin 8.83%)	$470M (margin 6.82%)	⚠️ $(292)M (margin -22.69%)	$(127)M (margin -13.03%)

Product Commerce's margin of 8.83% is its second-best quarter this site has tracked, well ahead of a year ago's 6.82% but a step down from Q2 2025's all-time high of 9.04%. Management attributes the segment's gross-profit growth (24% YoY, faster than its 15.8% revenue growth) to a rising share of higher-margin revenue - continued Fulfillment and Logistics by Coupang (FLC) merchant adoption and further supply-chain optimization - the same driver cited in prior quarters, just not enough this quarter to extend Q2's record.

Developing Offerings' dollar loss widened 130% YoY to $(292) million from $(127) million, and the margin regressed sharply - from -13.03% a year ago to -22.69% this quarter, reversing the improving trend this site tracked through 2024. Unlike prior quarters where a widening loss traced to Farfetch specifically, Coupang's own MD&A attributes this quarter's increase to "increased investments in our Developing Offerings initiatives, including Taiwan" - a different driver than the Farfetch-integration story that explained Q3 2024's numbers, and one that also pulled gross margin down within the segment (gross profit fell 22% YoY even as revenue grew 32%). This is a real deterioration, not a comparative-basis artifact, though it's disclosed as a deliberate investment choice rather than a surprise.

Key Operational Metrics

Quarter	Product Commerce Active Customers	Net revenues per Product Commerce Active Customer
Sep 2024	22.5M	$307
Dec 2024	22.8M	$302
Mar 2025	23.4M	$294
Jun 2025	23.9M	$307
Sep 2025	24.7M	$323

Product Commerce Active Customers^» grew 10% YoY to a new high of 24.7 million, the fourth straight quarter of double-digit growth. Net revenues per Product Commerce Active Customer^» hit a new high of $323, up 5% YoY nominal and 7% on a constant-currency basis - both customer growth and per-customer spend accelerating together this quarter, a cleaner combination than Q1 2025's gap between nominal and constant-currency growth.

"Not available" again this filing: orders per customer, Rocket WOW membership subscriber count, and third-party seller/merchant count - none disclosed, consistent with every prior quarter this site has tracked.

The Stock Climbed to a New High for This Window, Extending an Already Sharp Two-Year Round Trip

Coupang closed Q3 2025 (September 30, 2025) at $32.20, up 7.5% from Q2 2025's close of $29.96 and up 31.2% from a year earlier. That's the highest close in the trailing two-year window this site tracks, extending a run that started from a $14.00 low in January 2024 - a peak-to-trough move of more than 130% over roughly twenty months. Unlike a pure re-rating, this quarter's gain arrived alongside genuinely mixed operating results (record cash generation and a buyback that finally executed, but a Product Commerce margin that slipped and a Developing Offerings loss that widened) - the market extended last quarter's re-rating on the strength of the cash-flow and buyback news even as segment profitability cooled, which is worth remembering the next time the margin story reverses.

Beyond the Usual

The original IPO-era securities class action was dismissed in its entirety

On September 10, 2025, the U.S. District Court for the Southern District of New York dismissed New York City Public Pension Funds v. Coupang, Inc. et al. (formerly Choi v. Coupang) - the securities class action tracked since Q3 2022 alleging misstatements in Coupang's IPO registration statement, later amended to add Exchange Act fraud claims - in its entirety, without leave to amend. Plaintiffs filed a notice of appeal on October 10, 2025, so the matter isn't fully closed, but a full dismissal at the district court is a genuine, disclosed win after three years of this case sitting open with no lead plaintiff ever named. The related stockholder derivative actions and Board demands, which make substantially similar factual allegations, are unaffected by this ruling and remain pending.

The KFTC administrative case reached a sixth hearing and the criminal indictment held its first, both still unresolved

The KFTC administrative appeal tracked since Q4 2024 added a hearing in September 2025 as scheduled, with a sixth now set for November 2025 - five hearings held with no ruling yet on the underlying product-rankings finding. Separately, the criminal indictment against Coupang Corp. and CPLB held its first hearing in October 2025, with the next set for December 2025. The maximum penalty under the indictment remains a fine of approximately $200,000, still trivial next to the $121 million administrative fine already being paid in installments (final payment due June 2026). Coupang continues to state it will "vigorously defend" the charges. No new stockholder derivative suits or Board demands were disclosed this quarter beyond what's already pending.

A new unsecured term loan refinanced maturing secured debt, layered on top of the debt raised to redeem the Farfetch Term Loans

In September 2025, Coupang entered a new unsecured, three-year term loan agreement for $449 million, split across two tranches at an average fixed interest rate of 3.80%, specifically to refinance existing facility-backed secured loans maturing in April 2026 and March 2027 - retiring secured debt ahead of maturity in favor of unsecured financing, on top of the $425 million drawn on the new revolving credit facility in July to redeem the Farfetch Term Loans (confirmed fully redeemed this filing). Separately, Coupang also disclosed $953 million outstanding under various other unsecured revolving credit facilities entered during 2025, mostly due in 2026, at rates between 2.67% and 3.37%. Read together, none of this reduces Coupang's total debt - it's replacing secured, acquisition-linked, and shorter-dated obligations with unsecured facilities on the company's own credit - but it's a genuine simplification of the balance sheet's debt structure, not a leverage increase in substance.

Supplier financing arrangements - reverse-factoring balances embedded in accounts payable - grew 22% YoY

A new disclosure this filing shows confirmed invoices owed to financial institutions under supplier financing arrangements (a form of reverse factoring, where a bank pays Coupang's suppliers early and Coupang repays the bank on its own schedule) at $541 million as of September 30, 2025, up from $443 million a year earlier. These amounts sit inside accounts payable on the balance sheet rather than as a separate debt line - a common structure, but one that means a portion of what looks like ordinary trade payables growth is actually bank-financed working capital rather than extended supplier terms alone.

Coupang's Farfetch subsidiary settled with Authentic Brands Group LLC in February 2025, terminating a license agreement's guaranteed minimum royalty payments - eliminating $264 million of commitments that would otherwise have run over the license's eight remaining years. This is disclosed for the first time in this filing's MD&A overview rather than in a prior quarter's filing.

Coupang's own liquidity disclosure quantifies its forward fulfillment-center capex directly again this quarter: $365 million in remaining capital-expenditure commitments under construction contracts expected to complete over the next two years, down modestly from $374 million last quarter as spend gets recognized. Separately, Coupang entered new unconditional purchase obligations with remaining payments of $483 million through 2033 during the nine months ended September 30, 2025 - not directly comparable to the $668 million figure disclosed for the six months ended June 30, 2025, since these figures track remaining balances rather than a running cumulative total, but both confirm multi-year purchase commitments (technology services, fulfillment-center construction, content and software licensing) layered on top of the balance sheet.

The Farfetch/New Guards internal-control material weakness disclosure is unchanged again this quarter - still described as no longer existing because the restructured business shrank below the materiality threshold, not because the underlying IT and business-process controls were actually fixed, the same framing carried since Q1 2025.

Target Valuation Range

EV $53.5 billion, ~1.59x EV/Revenue. Bottom line: Coupang's EV/Revenue multiple extended to roughly 1.59x trailing-twelve-months, up from Q2 2025's ~1.53x - the stock kept re-rating even as the quarter's own margin numbers cooled from Q2's record, a gap worth watching rather than dismissing.

With 1,665 million Class A shares and 158 million Class B shares outstanding (1,823 million total) as of September 30, 2025, and a quarter-end close of $32.20, that implies a market capitalization of approximately $58.7 billion - up from Q2's $54.5 billion on both the higher share price and modest share-count growth.

Using cash and cash equivalents of $7.229 billion against total debt of approximately $1.989 billion, net cash comes to roughly $5.240 billion, putting enterprise value at approximately $53.5 billion - up from Q2's $49.5 billion.

Market cap → enterprise value	Q3 2025
Share price (period-end)	$32.20
Shares outstanding (Class A + B)	1,823 million
Market capitalization	$58.7 billion
Net cash (cash & equivalents less total debt)	$5.240 billion
Enterprise value	$53.5 billion

EV/Revenue sanity check	Q2 2025	Q3 2025	Change
Enterprise value	$49.5 billion	$53.5 billion	up
EV/Revenue	1.53x	1.59x	up

• EV/Revenue^» using trailing-twelve-months revenue (FY2024's $30.268 billion minus nine-months-2024's $22.303 billion plus nine-months-2025's $25.699 billion, or $33.664 billion): ~1.59x, up from Q2's ~1.53x - a smaller step than Q1-to-Q2's move out of the 1.1x-1.2x band, but still extending the same direction.

DCF and reverse DCF (illustrative only): nineteen quarters of public-company data now cover Q3 2021 through Q3 2025. Checking this quarter against Q2 2025's base case:

Scenario	Assumption / outcome
Current (period-end close)	Actual EV/Revenue this quarter, for reference: 1.59x
Q2 2025 base case	The Q2 2025 base case called for the KFTC matters to continue without near-term resolution, Product Commerce's margin to hold in the high-8s to 9% range, the buyback to remain largely unused, and the multiple to settle in the 1.3x-1.5x range. Two of four landed close to base case: the KFTC matters remain unresolved (see Beyond the Usual), and Product Commerce's margin held at 8.83%, inside the projected range. The other two beat base case toward the bull scenario: the buyback didn't stay "largely unused" - Coupang actually executed $81 million of it, exactly what the bull case called "beginning to actually execute" - and the multiple didn't settle in 1.3x-1.5x, it extended to ~1.59x, past the bull case's ">1.5x" threshold. Developing Offerings' losses, which the bull case hoped would resume narrowing, instead widened - the one clear miss.
Bear case for next quarter	Bear case for next quarter: the November 2025 KFTC hearing or the December 2025 indictment hearing produces an adverse ruling, Developing Offerings' loss keeps widening on continued Taiwan investment, and the multiple gives back some of this quarter's gain as the market notices the margin cooling.
Base case for next quarter	Base case for next quarter: the KFTC matters continue without near-term resolution, Product Commerce's margin holds in the high-8s%, the buyback continues at a similar modest pace, and the multiple holds roughly in the 1.5x-1.7x range - Q4's holiday-season seasonality typically Coupang's strongest quarter for both revenue and Product Commerce margin, so a seasonal lift on top of the base case wouldn't be a surprise.
Bull case for next quarter	Bull case for next quarter: the buyback pace accelerates meaningfully beyond this quarter's $81 million, Developing Offerings' loss narrows again as the Taiwan investment phase matures, Q4 seasonality pushes Product Commerce's margin to a new high past Q2's 9.04% record, and the multiple extends further past 1.7x.

---